Report : A-Z HCD items in Formulary 25/01/2021 01:41:55
[
Back
]
Section
Status
BlueTeq
Name
01.05.03
Formulary
Adalimumab
02.12
Formulary
Alirocumab Praluent®
13.05.02
Formulary
Apremilast Otezla®
09.01.04
Formulary
Avatrombopag Doptelet®
04.12
Formulary
Botulinum neurotoxin Type A Xeomin
®
09.01.04
Formulary
Eltrombopag Revolade
®
02.12
Formulary
Evolocumab Repatha®
06.01.06
Formulary
Flash glucose monitoring system FreeStyle Libre
®
04.07.04.02
Formulary
Fremanezumab
01.05.03
Formulary
Golimumab Simponi
®
01.05.03
Formulary
Infliximab
09.01.04
Formulary
Lusutrombopag Mulpleo
®
03.04.02
Restricted Use
Omalizumab
13.05.03
Formulary
Risankizumab Skyrizi®
09.01.04
Formulary
Romiplostim Nplate
®
01.05.03
Formulary
Tofacitinib Xeljanz
®
10.01.03
Formulary
Tofacitinib Xeljanz
®
01.05.03
Formulary
Ustekinumab Stelara
®
13.05.03
Formulary
Ustekinumab
01.05.03
Formulary
Vedolizumab Entyvio
®
South Staffordshire Joint Formulary